Arffman M, Meriranta L, Jørgensen J, Karjalainen-Lindsberg ML, Beiske K, Pedersen M, Drott K, Fluge Ø, Jyrkkiö S, Brown P, Holte H, Leppä S(2026) A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas Leukemia, 40(7), 1381-1391 DOI 10.1038/s41375-026-02955-w, PubMed 42020781
Dreyling M, Doorduijn J, Giné E, Jerkeman M, Walewski J, Hutchings M, Mey U, Riise J, Trneny M, Vergote VKJ, Shpilberg O, da Silva MG, Leppä S, Jiang L, Stilgenbauer S, Kerkhoff A, Jachimowicz RD, Heß G, Meerten TV, Wirths S, Herhaus P, Novak U, Dierlamm J, Hänel M, Hanoun Cet al.(2026) Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network Lancet, 407(10542), 1953-1967 DOI 10.1016/S0140-6736(26)00362-4, PubMed 42134356
Eichenauer DA, André M, Borchmann P, Collins GP, Doherty I, Eich HT, Federico M, Fossa A, Hartmann S, Hutchings M, Illidge T, Kobe C, Plattel WJ, Specht L, Sureda A, Zaucha JM, Zijlstra JM, Aurer I(2026) Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up Hemasphere, 10(6), e70422 DOI 10.1002/hem3.70422, PubMed 42345030
